Polycythemia
Polycythemia is characterized by red blood cell count, hemoglobin, hematocrit and total blood volume significantly exceeding normal levels. In childhood, hemoglobin exceeds 180g/L (16g/dl), hematocrit is greater than 55% and the absolute value of red blood cell volume per kilogram of body weight exceeds 35ml. Relative erythrocytosis caused by blood concentration due to acute dehydration or burns can be excluded, and the disease can be diagnosed. This disease can be divided into two categories: primary and secondary. Primary is true polycythemia; secondary is mainly caused by tissue hypoxia.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Adults -
Related symptoms:
Dizziness fatigue forgetfulness itchy skin double vision -
Concurrent disease:
Relative erythrocytosis Secondary erythrocytosis Hereditary xerocytosis Stomatocytosis Hereditary elliptocytosis
Related Drugs
Vitamin E Injection
Indication: This product is only suitable for acanthocytosis or malabsorption syndrome.
Vitamin E Injection
Indication: This product is only suitable for acanthocytosis or malabsorption syndrome.
Manufacturer:
Yaopharma Co., Ltd.
Vitamin E Injection
Indication: This product is only suitable for acanthocytosis or malabsorption syndrome.
Manufacturer:
Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Co., Ltd.
Xinnaoxin Pills
Manufacturer:
Kangmei Baoning(Sichuan)Pharmaceutical Co., Ltd.
Xinnaoxin Pills
Manufacturer:
Jiangsu Kanion Pharmaceutical Co., Ltd.
Busulfan Injection
Indication: It is mainly used in the chronic phase of chronic myeloid leukemia, and has poor effects on patients lacking the Philadelphia chromosome Ph1. It can also be used to treat chronic myeloproliferative diseases such as essential thrombocythemia and polycythemia vera.
Melphalan Tablets
Indication: 1. Melphalan tablets are suitable for the treatment of multiple myeloma and advanced ovarian adenocarcinoma. 2. Melphalan, used alone or in combination with other drugs, has a significant effect on some patients with advanced breast cancer. 3. Melphalan is effective for some patients with polycythemia vera. Melphalan has also been used as an adjuvant drug for surgical treatment of breast cancer.
Homoharringtonine for injection
Indication: This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Xi'an Disai Biopharmaceutical Co., Ltd.
Homoharringtonine for injection
Indication: This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Xi'an Disai Biopharmaceutical Co., Ltd.
Lishukang Capsules
Manufacturer:
Qinghai Yixin Pharmaceutical Co., Ltd.
Related Ingredients
-
Vitamin E list
2074-53-5 -
Busulfan list
55-98-1 -
Homoharringtonine list
26833-87-4 -
Gymnoside III list
899430-03-6